Table 2.
Tumor 1 | CTC 2 | Outcome 3 | Metastasis 4 | Ref. |
---|---|---|---|---|
BC | EpCAM+CD44+CD47+MET+ | OS 6 | NSG mice; bone mets 5 | [126] |
BC | EpCAM−HER2+EGFR+HPSE+NOTCH1+ | NA 7 | Nude mice; lung met 8, brain met 9 | [127] |
CRC | CTC lines with CSC properties | NA 7 | Nude mice; lung and liver met 10 | [128] |
PC | CK+Vimentin+CD45− | Met 11 | NA 7 | [100] |
1 BC: breast cancer, CRC: colorectal cancer, PC: prostate cancer; 2 CTC types; 3 clinical outcome; 4 mouse model; 5 femoral medullar cavity implantation; 6 reductions in overall survival; 7 not available; 8 tail vein injection; 9 intracardiac injection; 10 spleen injection; 11 association with metastasis.